NCT00086840 2013-01-24CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI)Phase 2 Terminated60 enrolled
NCT00101088 2013-01-14Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated21 enrolled